Applications of FDG PET in Oncology
Best Clinical Practice
(Sprache: Englisch)
This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
98.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Applications of FDG PET in Oncology “
Klappentext zu „Applications of FDG PET in Oncology “
This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.Inhaltsverzeichnis zu „Applications of FDG PET in Oncology “
1Overview.-2Lung cancer.-3Breast cancer.- 4Head and neck cancer.-5Gastrointestinal cancer including GIST.- 6Pancreatic cancer.- 7Urological cancer.- 8Malignant bone and soft tissue tumors.- 9 Skin cancer including malignant melanoma.- 10Malignant lymphoma.Autoren-Porträt
Hirofumi Fujii M.D., Ph.D. Division of Functional Imaging
Exploratory Oncology Research and Clinical Trial Center
National Cancer Center
Kashiwa, Japan
Professor Hiroyuki Nakamura, M.D., Ph.D.
Department of Respiratory Medicine
Tokyo Medical University Ibaraki Medical Center
Ibaraki, Japan
Seiei Yasuda, M.D., Ph.D.
Chairman of the board of trustee
Yotsuya Medical Cube
Tokyo, Japan
Bibliographische Angaben
- 2021, 1st ed. 2021, VII, 147 Seiten, 55 farbige Abbildungen, Maße: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Herausgegeben: Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda
- Verlag: Springer, Berlin
- ISBN-10: 9811584257
- ISBN-13: 9789811584251
Sprache:
Englisch
Pressezitat
"The book provides a detailed and insightful perspective ... . It would make an interesting read for the inquisitive PETCT scholar, and it would be an invaluable tool for the reader who is interested in comparing PETCT practices across various jurisdictions." (Wai Lup Wong, RAD Magazine, January, 2023)
Kommentar zu "Applications of FDG PET in Oncology"
Schreiben Sie einen Kommentar zu "Applications of FDG PET in Oncology".
Kommentar verfassen